Essex Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
VCM
VAM
Essex Financial Services's AZN Position: Q1 2026 in Review
Essex Financial Services increased its AstraZeneca (AZN) stake by 2.4% in Q1 2026, buying an estimated $23.3K and bringing the position to 5,122 shares worth $1M. The position accounts for 0.06% of the portfolio, ranked #289.
Essex Financial Services first reported a position in AZN in Q3 2021 and has held it in 19 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Essex Financial Services held 5,122 shares of AstraZeneca worth $1M as of Q1 2026.
- Essex Financial Services bought 121 AstraZeneca shares in Q1 2026, an estimated $23.3K.
- AstraZeneca made up 0.06% of Essex Financial Services's portfolio in Q1 2026, its #289 holding.
- Essex Financial Services first reported a position in AstraZeneca in Q3 2021 and has held it in 19 quarters since.
- 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.